Associated tags: PSG, Pharmacy, Health insurance, Pharmaceutical industry, Fine chemical, PBM, MPH, Doctor of Philosophy, CPH, Research, Health
Locations: UNITED STATES, NORTH AMERICA, TEXAS
Professional Services,
Health,
Insurance,
Health Insurance,
Human Resources,
Pharmaceutical,
Biotechnology,
PSG,
Pharmacy,
Data,
Research,
SVP,
Growth,
Management Pharmaceutical Strategies Group (“ PSG ”), an EPIC company , has added two significant enhancements to its leadership team aimed at further empowering healthcare payers and driving innovation within the pharmacy benefits industry.
Key Points:
- Pharmaceutical Strategies Group (“ PSG ”), an EPIC company , has added two significant enhancements to its leadership team aimed at further empowering healthcare payers and driving innovation within the pharmacy benefits industry.
- “With these leadership enhancements, we are better positioned than ever to help our clients navigate the complexities of the pharmacy supply chain, driving both innovation and success."
- These efforts aim to enhance strategic decision-making for healthcare payers, ensuring their pharmacy benefit programs align with their overarching goals.
- Gregg’s time at PSG has been marked by significant growth in her scope and span of control, making this promotion a reflection of her current leadership.
Health,
Genetics,
Health Insurance,
Managed Care,
Pharmaceutical,
Biotechnology,
PSG,
Pharmacy,
Investment,
CPH,
Research,
Roche,
Genentech,
Doctor of Philosophy,
Growth,
Patient,
MPH,
Adalimumab,
Quality of life Pharmaceutical Strategies Group (“ PSG ”), an EPIC company , released its annual Trends in Specialty Drug Benefits Report , co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability.
Key Points:
- Pharmaceutical Strategies Group (“ PSG ”), an EPIC company , released its annual Trends in Specialty Drug Benefits Report , co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability.
- The proprietary research spotlights how employers and health plans are navigating the increasingly complex landscape of specialty drug access for patients.
- Advancements in drug therapies allow patients with conditions treated by specialty drugs to live longer and have improved quality of life.
- Top concerns are access to reliable data on the total cost of care impact of medications, followed by the affordability of specialty drug cost-sharing amounts for members.
Retrieved on:
Thursday, September 14, 2023
General Health,
Consulting,
Health,
Professional Services,
Pharmaceutical,
PBM,
PSG,
RFP,
Organization,
NPS,
Growth,
Pharmacy,
Amazon Pharmacy,
Retail Satisfaction with pharmacy benefit managers (PBMs) has plunged to its lowest level in nearly a decade, according to Pharmaceutical Strategies Group’s newly-released 2023 Pharmacy Benefit Manager Customer Satisfaction Report.
Key Points:
- Satisfaction with pharmacy benefit managers (PBMs) has plunged to its lowest level in nearly a decade, according to Pharmaceutical Strategies Group’s newly-released 2023 Pharmacy Benefit Manager Customer Satisfaction Report.
- Respondents’ mean overall satisfaction with their PBMs is 7.6 on a 1-10 scale, representing a material drop from a height of 8.2 in 2021 and the lowest overall satisfaction since 2014.
- Rising drug trend, predominantly negative public perception, and targeted political rhetoric likely have contributed to the decline in satisfaction.
- Diminishing satisfaction with these goliaths may create avenues of potential growth for competitors, who have higher customer satisfaction across multiple metrics,” said Mike Lonergan, president of PSG.
Pharmaceutical,
Professional Services,
Health,
Insurance,
Spend,
PSG,
Pharmacy,
Senior,
History,
Multiple sclerosis,
Walmart,
Patient,
Annual report,
Fine chemical Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its proprietary Artemetrx ® State of Specialty Spend and Trend report, sponsored by Walmart.
Key Points:
- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its proprietary Artemetrx ® State of Specialty Spend and Trend report, sponsored by Walmart.
- The seventh annual report uses integrated pharmacy and medical claims data to provide a holistic view of specialty drug spend and trend.
- First published in 2017, this report is the sole comprehensive analysis of specialty drug spending, powered by the industry’s leading integrated dataset through Artemetrx.
- Specialty drug trend continued to be driven primarily by claim utilization, accounting for nearly three-quarters of the overall 14.1% gross trend.
PSG,
Cost sharing,
Doctor of Pharmacy,
Senior,
Weight loss,
CPH,
Pharmacy,
Doctor of Philosophy,
Research strategies of election campaign communication research,
Patient,
PBM,
Ecosystem,
FDA,
MPH,
Pharmaceutical industry,
Health insurance,
Music DALLAS, June 13, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report. The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit. Sponsored by Rx Savings Solutions, it outlines the complexities of designing and managing the drug benefit and the cost challenges faced by consumers and plan sponsors alike.
Key Points:
- DALLAS, June 13, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report.
- The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit.
- Since the inception of this report, the drug benefit has become more intricate to design and manage.
- This report helps benefit leaders identify trends and future possibilities so they can adjust as appropriate around these factors and more.
PSG,
VBC,
Fad,
CPH,
Research,
Intelligence,
MPH,
Pharmacy,
Doctor of Philosophy,
Pharmacist,
Fine chemical,
Health insurance,
Pharmaceutical industry,
Medical device DALLAS, May 1, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report.
Key Points:
- DALLAS, May 1, 2023 /PRNewswire/ -- Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report.
- Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research.
- This report takes a detailed look into what plan sponsors are facing as they make decisions relative to specialty drug benefit plan design.
- Download the Trends in Specialty Drug Benefits Report and register for the 5/10/23 webinar here: https://www.psgconsults.com/2023specialtybdr-webinar
DALLAS, Jan. 23, 2023 /PRNewswire/ -- Artemetrx®, the industry's most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.
Key Points:
- With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.
- With Artemetrx Extend, our clients will be able to further tap into the rich integrated dataset of the Artemetrx platform," said Libby Johnson, PSG Chief Data and Analytics Officer.
- Artemetrx is a proprietary industry-leading web-based software for integrated drug management developed by Pharmaceutical Strategies Group.
- Artemetrx Extend is the latest in a series of innovations on the Artemetrx platform.
Retrieved on:
Thursday, December 9, 2021
Pharmacy benefit management,
Pharmacy,
Research,
Health,
PBM,
Lead,
Delivery,
Industry,
PSG,
Financial statement,
Conflict of interest,
LLC,
Finance,
Interest,
Mark (given name),
Solution,
Fine chemical,
Health insurance,
Pharmaceutical industry BONITA SPRINGS, Fla., Dec. 9, 2021 /PRNewswire/ --Plan sponsors have again ranked BeneCard PBF as the leader in customer satisfaction with an overall rating of 9.9 out of 10 in the 2021 Pharmacy Benefit Manager (PBM) Customer Satisfaction Report from Pharmaceutical Strategies Group, LLC (PSG).
Key Points:
- BONITA SPRINGS, Fla., Dec. 9, 2021 /PRNewswire/ --Plan sponsors have again ranked BeneCard PBF as the leader in customer satisfaction with an overall rating of 9.9 out of 10 in the 2021 Pharmacy Benefit Manager (PBM) Customer Satisfaction Report from Pharmaceutical Strategies Group, LLC (PSG).
- Focused on putting members and clients Always First, BeneCard PBF has been a leader in PSG's report for seven years.
- The importance of PBM functions vary by customer needs, and BeneCard PBF is successful in all areas.
- "BeneCard PBF was founded on the principle that if you take care of people delivering the best clinical care at the best value plan savings would naturally follow," remarked Kenneth D. Ullman, Chairman of BeneCard PBF.
